Type
Business expansion
Country
Belgium
Region
Vlaams Gewest; Prov. Antwerpen; Arr. Mechelen
Location of affected unit(s)
Puurs
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.10 - Manufacture of basic pharmaceutical products

100 jobs
Number of planned job creations
Job creation
Announcement Date
11 February 2015
Employment effect (start)
Foreseen end date

Description

The multinational producer of pharmaceutical products, Pfizer, has invested 75 million euro in a production unit creating sterile doses of the pneumococcal vaccine Prevenar 13 at its Puurs facility, creating 100 extra jobs. Employment here has grown from 1,100 employees in 2010 to a scheduled 1,600 employees at the end of 2016.

The managing director indicated that one of the attractions for the US company to invest in Puurs has been the good technical training of employees.  The production of this specific vaccine was done to date in the United States. 


Sources

  • 11 February 2015: De Standaard

Citation

Eurofound (2015), Pfizer, Business expansion in Belgium, factsheet number 78607, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/78607.